Cornerstone Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Buy
22,273
+191
+0.9% +$22.4K 0.12% 161
2026
Q1
$2.66M Sell
22,082
-534
-2% -$61.6K 0.13% 155
2025
Q4
$2.38M Sell
22,616
-94
-0.4% -$8.82K 0.12% 162
2025
Q3
$1.91M Buy
22,710
+133
+0.6% +$11K 0.11% 180
2025
Q2
$1.79M Buy
22,577
+840
+4% +$66.8K 0.11% 166
2025
Q1
$1.95M Sell
21,737
-365
-2% -$34.1K 0.13% 151
2024
Q4
$2.2M Buy
22,102
+821
+4% +$84.6K 0.15% 139
2024
Q3
$2.42M Buy
21,281
+452
+2% +$53.7K 0.17% 122
2024
Q2
$2.58M Sell
20,829
-65
-0.3% -$8.37K 0.2% 108
2024
Q1
$2.76M Sell
20,894
-117
-0.6% -$14.4K 0.22% 100
2023
Q4
$2.29M Buy
21,011
+19
+0.1% +$1.97K 0.2% 113
2023
Q3
$2.16M Buy
20,992
+1,377
+7% +$148K 0.2% 111
2023
Q2
$2.26M Sell
19,615
-105
-0.5% -$11.9K 0.2% 114
2023
Q1
$2.1M Buy
+19,720
New +$2.13M 0.21% 107
2022
Q3
$1.72M Buy
19,992
+556
+3% +$49.6K 0.19% 110
2022
Q2
$1.77M Buy
19,436
+442
+2% +$39.2K 0.2% 110
2022
Q1
$1.56M Buy
18,994
+1,299
+7% +$102K 0.15% 132
2021
Q4
$1.36M Buy
17,695
+1,556
+10% +$124K 0.13% 150
2021
Q3
$1.21M Sell
16,139
-128
-0.8% -$9.73K 0.13% 158
2021
Q2
$1.26M Buy
16,267
+1,100
+7% +$81.8K 0.13% 153
2021
Q1
$1.12M Buy
15,167
+558
+4% +$41.2K 0.13% 159
2020
Q4
$1.14M Buy
14,609
+4,070
+39% +$311K 0.14% 139
2020
Q3
$834K Buy
10,539
+440
+4% +$34.5K 0.12% 160
2020
Q2
$745K Buy
10,099
+1,060
+12% +$79.8K 0.12% 168
2020
Q1
$664K Buy
9,039
+782
+9% +$61.5K 0.13% 163
2019
Q4
$717K Buy
8,257
+768
+10% +$63.1K 0.12% 166
2019
Q3
$602K Sell
7,489
-1,193
-14% -$95.6K 0.11% 183
2019
Q2
$691K Buy
8,682
+2,046
+31% +$157K 0.12% 169
2019
Q1
$1.1M Sell
6,636
-144
-2% -$10.8K 0.13% 175
2018
Q4
$489K Sell
6,780
-584,866
-99% -$41.3M 0.1% 197
2018
Q3
$8.78M Buy
591,646
+225,566
+62% +$14.4M 0.11% 197
2018
Q2
$5.78M Buy
366,080
+359,420
+5,397% +$20.3M 0.07% 288
2018
Q1
$340K Sell
6,660
-278
-4% -$15K 0.06% 277
2017
Q4
$372K Sell
6,938
-2,260
-25% -$125K 0.07% 269
2017
Q3
$570K Buy
9,198
+399
+5% +$24.2K 0.12% 176
2017
Q2
$530K Buy
8,799
+460
+6% +$28K 0.12% 170
2017
Q1
$510K Buy
8,339
+289
+4% +$17.5K 0.13% 166
2016
Q4
$463K Buy
8,050
+164
+2% +$9.6K 0.15% 141
2016
Q3
$469K Buy
+7,886
New +$461K 0.17% 123

Other funds holding MRK

Cornerstone Wealth Management's MRK Position: Q2 2026 in Review

Cornerstone Wealth Management increased its Merck (MRK) stake by 0.86% in Q2 2026, buying an estimated $22.4K and bringing the position to 22,273 shares worth $2.86M. The position accounts for 0.12% of the portfolio, ranked #161.

Cornerstone Wealth Management first reported a position in MRK in Q3 2016 and has held it in 39 quarters since. The position peaked at $8.78M in Q3 2018. 1,109 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cornerstone Wealth Management held 22,273 shares of Merck worth $2.86M as of Q2 2026.
  • Cornerstone Wealth Management bought 191 Merck shares in Q2 2026, an estimated $22.4K.
  • Merck made up 0.12% of Cornerstone Wealth Management's portfolio in Q2 2026, its #161 holding.
  • Cornerstone Wealth Management first reported a position in Merck in Q3 2016 and has held it in 39 quarters since.
  • Cornerstone Wealth Management's Merck position peaked at $8.78M in Q3 2018.
  • 1,109 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.